| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/10/2013 | CN103193779A Eszopiclone preparation method |
| 07/10/2013 | CN103193697A Light-emitting device material and light-emitting device |
| 07/10/2013 | CN103193560A Nitramine explosive and preparation method thereof |
| 07/10/2013 | CN102344549B Porphyrin-pyrrolopyrrole copolymer containing carbazole, preparation method thereof and application thereof |
| 07/10/2013 | CN101878216B Pyrimidine derivatives as protein kinase inhibitors |
| 07/10/2013 | CN101821267B Compounds for the treatment of hepatitis c |
| 07/10/2013 | CN101781302B Adduct generated from phosphodiesterase inhibitor and isoflavone and application thereof |
| 07/10/2013 | CN101495480B Constrained compounds as cgrp-receptor antagonists |
| 07/10/2013 | CN101130526B Aryl carbonyl derivatives as therapeutic agents |
| 07/09/2013 | USRE44354 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/09/2013 | US8481750 Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides |
| 07/09/2013 | US8481733 Substituted imidazopyr- and imidazotri-azines |
| 07/09/2013 | US8481731 Compounds, pharmaceutical composition and methods relating thereto |
| 07/09/2013 | US8481585 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/09/2013 | US8481545 3-(imidazolyl)-pyrazolo[3,4-b] pyridines |
| 07/09/2013 | US8481538 Heterocyclic inhibitors of c-Met and uses thereof |
| 07/09/2013 | US8481528 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/09/2013 | US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
| 07/09/2013 | CA2608726C Inhibitors of vegf receptor and hgf receptor signaling |
| 07/09/2013 | CA2580610C Diaminotriazole compounds useful as protein kinase inhibitors |
| 07/04/2013 | WO2013102059A1 Pyrazolo [3, 4-d] pyrimidine and pyrrolo [2, 3-d] pyrimidine compounds as kinase inhibitors |
| 07/04/2013 | WO2013101802A1 Nicotinic receptor compounds |
| 07/04/2013 | WO2013100872A1 One pot process for preparing pemetrexed disodium |
| 07/04/2013 | WO2013097225A1 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors |
| 07/04/2013 | WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/04/2013 | WO2013097052A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013054364A3 Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof |
| 07/04/2013 | WO2013019561A8 Nuclear transport modulators and uses thereof |
| 07/04/2013 | US20130172549 Heteroaryl amide derivatives |
| 07/04/2013 | US20130172396 Use of derivatives of pentaphyrine as antimicrobial and disinfectant agents |
| 07/04/2013 | US20130172373 Quinazoline compounds |
| 07/04/2013 | US20130172369 Processes for the preparation of dipyridamole |
| 07/04/2013 | US20130172360 Derivatives of azaindazole or diazaindazole type as medicament |
| 07/04/2013 | US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 07/04/2013 | US20130172325 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 07/04/2013 | US20130172319 Alpha-AminoCycloLactam Ligands for G-Protein Coupled Receptors, and Methods of Using Same |
| 07/04/2013 | US20130172314 PYRAZOLO[3,4-d]PYRIMIDINE AND PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS KINASE INHIBITORS |
| 07/04/2013 | US20130171102 Heterocyclic flaviviridae virus inhibitors |
| 07/04/2013 | US20130168659 Semiconducting Compounds and Related Compositions and Devices |
| 07/04/2013 | CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/04/2013 | CA2856309A1 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors |
| 07/03/2013 | EP2610256A1 Pyrimidine derivatives as protein kinase inhibitors |
| 07/03/2013 | EP2609099A2 Sitagliptin, salts and polymorphs thereof |
| 07/03/2013 | EP2609098A1 Triazolopyrazine derivatives |
| 07/03/2013 | EP2609064A2 Pharmaceutical compositions comprising poh derivatives |
| 07/03/2013 | EP2608785A2 Lipomacrocycles and uses thereof |
| 07/03/2013 | CN103189379A Bicyclic pyrimidines |
| 07/03/2013 | CN103189378A Pyrazolopyridinone derivatives as LPA receptor antagonists |
| 07/03/2013 | CN103189369A Pyridinones/pyrazinones, method of making, and method of use thereof |
| 07/03/2013 | CN103188934A Nematocidal sulfonamides |
| 07/03/2013 | CN103183679A 抗凝血化合物及其应用 Anticoagulant compound and Applications |
| 07/03/2013 | CN102201540B Organic electroluminescence component |
| 07/03/2013 | CN101945877B Pyrrolopyrazine kinase inhibitors |
| 07/03/2013 | CN101600718B Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 07/02/2013 | USRE44338 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/02/2013 | US8476453 Process for the preparation of dimiracetam |
| 07/02/2013 | US8476431 Benzoxazole kinase inhibitors and methods of use |
| 07/02/2013 | US8476430 Fused heterocyclic compounds useful as kinase modulators |
| 07/02/2013 | US8476283 [6,5]—bicyclic GPR119 G protein-coupled receptor agonists |
| 07/02/2013 | US8476282 Benzoxazole kinase inhibitors and methods of use |
| 07/02/2013 | US8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor |
| 07/02/2013 | US8475686 Bridged pyridoquinazoline or phenanthroline compounds and organic semiconducting material comprising that compound |
| 07/02/2013 | CA2731897C Diazepine and diazocane compounds as mc4 agonists |
| 07/02/2013 | CA2619136C Process for making titanyl phthalocyanine |
| 07/02/2013 | CA2578368C Triazolophthalazines |
| 06/27/2013 | WO2013096971A1 Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst |
| 06/27/2013 | WO2013096681A1 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013095304A1 Processes for preparing indoles |
| 06/27/2013 | WO2013093497A1 2 - (pyridin- 2yl) - 1, 7 -diaza- spiro [4.4] nonane- 6 -one compounds as voltage - gated sodium channels modulators |
| 06/27/2013 | WO2013093496A1 2 - (pyridin- 2yl) - 1, 7 -diaza-spiro [4.4] nonane- 6 -one compound as voltage-gated sodium channels modulator |
| 06/27/2013 | WO2013093484A1 Pyridinone and pyrimidinone derivatives as factor xia inhibitors |
| 06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | WO2013092940A1 2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors |
| 06/27/2013 | WO2013092900A1 Synthesis of triazolopyrimidine compounds |
| 06/27/2013 | WO2013092444A1 Diazaindole inhibitors of crac |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | WO2013091011A1 Heterocyclic urea compounds |
| 06/27/2013 | WO2013024474A8 Polymorphs of preladenant |
| 06/27/2013 | US20130165654 Processes for preparing pemetrexed |
| 06/27/2013 | US20130165651 FUSED BICYCLIC mTOR INHIBITORS |
| 06/27/2013 | US20130165647 Stereoselective total synthesis of noribogaine |
| 06/27/2013 | US20130165457 Inhibitors of e1 activating enzymes |
| 06/27/2013 | US20130165454 Compounds and compositions for treating chemical warefare agent-induced injuries |
| 06/27/2013 | US20130165448 Aildenafil citrate crystal form o, preparation method and use thereof |
| 06/27/2013 | US20130165447 Inhibitors of PDE10 |
| 06/27/2013 | US20130165446 Benzo-or pyrido-imidazole derivative |
| 06/27/2013 | US20130165445 Aurora Kinase Modulators and Method of Use |
| 06/27/2013 | US20130165431 Inhibitors of syk and jak protein kinases |
| 06/27/2013 | US20130165426 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 06/27/2013 | US20130165425 Sulfate esters of noribogaine |
| 06/27/2013 | US20130165424 Dispiropyrrolidine derivatives |
| 06/27/2013 | US20130165414 Phosphate esters of noribogaine |
| 06/27/2013 | US20130164280 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
| 06/27/2013 | CA2858096A1 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/27/2013 | CA2854248A1 2,4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors |
| 06/26/2013 | EP2607355A1 Synthesis of triazolopyrimidine compounds |
| 06/26/2013 | EP2606052A1 Nicotinic receptor compounds |